Walgreens launches private label opioid overdose reversal agent

U.S. pharmacy chain operator Walgreens Boots Alliance (WBA-US) announced on Wednesday (15th) the launch of its own brand of the popular overdose reversal drug naloxone, which will be sold over-the-counter (OTC).

U.S. pharmacy chain operator Walgreens Boots Alliance (WBA-US) announced on Wednesday (15th) the launch of its own brand of the popular overdose reversal drug naloxone, which will be sold over-the-counter (OTC).
The U.S. Food and Drug Administration (FDA) approved Walgreens\’ private label brand in April.
Opioid abuse has plagued the United States for more than two decades and killed more than 500,000 Americans, according to government data, with fentanyl and synthetic drugs being the main culprits in recent years.
Naloxone can quickly reverse, or block, the effects of opioids and restore normal breathing, especially if given within minutes of the first signs of overdose.
It\’s seen as a key tool in helping people survive an opioid overdose.
The U.S. FDA last year approved an over-the-counter version of Emergent Biosolutions\’ naloxone (Narcan) to make it easier to obtain without a prescription.
Health regulators approved the drug\’s first generic version in 2021, marketed by Israeli drugmaker Teva Pharmaceuticals.
Other drugmakers also sell versions of the product. Privately held Harm Reduction Therapeutics\’ naloxone-based nasal spray RiVive has also been approved for sale without a prescription.
Walgreens said its naloxone-based drug, \”Naloxone Hydrochloride Nasal Spray,\” is currently available for purchase on its website and will be available in all of its stores by the end of the month.
Each pack retails for $34.99. Each pack contains two single doses of 4 mg each.
The OTC version of Emergent BioSolutions\’ Narcan sells for about $50 per case.

Like (0)
Previous May 15, 2024 4:20 pm
Next May 15, 2024 4:20 pm

Related posts